Atea Pharmaceuticals Q1 EPS $(0.40) Beats $(0.41) Estimate
Benzinga Newsdesk 1 year ago
EarningsEarnings BeatsNews
Atea Pharmaceuticals (NASDAQ:AVIR) reported quarterly losses of $(0.40) per share which beat the analyst consensus estimate of $(0.41) by 2.44 percent. This is a 46.67 percent increase over losses of $(0.75) per share
Atea Pharmaceuticals (NASDAQ:AVIR) reported quarterly losses of $(0.40) per share which beat the analyst consensus estimate of $(0.41) by 2.44 percent. This is a 46.67 percent increase over losses of $(0.75) per share from the same period last year.